Pak Fah Yeow International Limited AI Stock Analysis
Want to see HK:0239 full AI Analyst Report?
Pak Fah Yeow International Limited (0239) AI Stock Analysis
Pak Fah Yeow International Limited
(HKEX:0239)
The company's exceptional financial health, marked by high profitability, a debt-free balance sheet, and strong cash generation, is the primary driver of the score. This is complemented by a highly attractive valuation with a low P/E and a substantial dividend yield. Technical trends are supportive, with the stock trading above key moving averages and exhibiting positive momentum.
Pak Fah Yeow International Limited (0239) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 724.56M
- Dividend Yield
- 8.58%
- Average Volume (3M)
- 59.96K
- Price to Earnings (P/E)
- 7.3
- Beta (1Y)
- -0.06
- Revenue Growth
- 10.63%
- EPS Growth
- 39.44%
- Country
- Hong Kong
- Employees
- 100
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Drug Manufacturers - Specialty & Generic
Pak Fah Yeow International Limited Business Overview & Revenue Model
Company Description
Pak Fah Yeow International Limited, operating with its subsidiaries, specializes in the production, promotion, and distribution of healthcare goods under the Hoe Hin brand. Its market reach spans the People's Republic of China, Hong Kong, Macau, Sout...
Pak Fah Yeow International Limited Financial Statement Overview
Summary
Strong profitability with net margin of 42.7% and expanding EBIT margin. Exceptional balance sheet with near-zero debt and high equity. Robust cash flow exceeding net income. Revenue decline in recent years is a minor concern.
Income Statement
80PositiveBalance Sheet
95Very PositiveCash Flow
88Very Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 220.18M | 213.88M | 236.91M | 259.31M | 147.20M | 139.82M |
| Gross Profit | 140.54M | 133.14M | 203.20M | 167.59M | 74.06M | 68.71M |
| EBITDA | 133.21M | 115.35M | 105.73M | 136.81M | 45.90M | 54.67M |
| Net Income | 98.95M | 91.35M | 78.63M | 105.04M | 29.95M | 38.19M |
Balance Sheet | ||||||
| Total Assets | 878.30M | 828.37M | 843.35M | 907.47M | 823.14M | 837.75M |
| Cash, Cash Equivalents and Short-Term Investments | 400.27M | 344.54M | 290.02M | 277.61M | 180.34M | 178.28M |
| Total Debt | 6.95M | 6.87M | 4.20M | 4.74M | 5.50M | 16.21M |
| Total Liabilities | 144.25M | 105.63M | 111.45M | 142.28M | 115.91M | 130.03M |
| Stockholders Equity | 734.04M | 722.75M | 731.91M | 765.18M | 707.23M | 707.72M |
Cash Flow | ||||||
| Free Cash Flow | 91.38M | 112.33M | 78.02M | 144.84M | 39.76M | 69.54M |
| Operating Cash Flow | 97.80M | 112.77M | 78.96M | 147.90M | 39.92M | 70.36M |
| Investing Cash Flow | -5.78M | -63.29M | -3.19M | 16.65M | -6.67M | -565.00K |
| Financing Cash Flow | -57.60M | -57.67M | -67.54M | -48.96M | -33.91M | -22.41M |
Pak Fah Yeow International Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0239, the sentiment is Negative. The current price of 2.33 is below the 20-day moving average (MA) of 2.42, below the 50-day MA of 2.40, and above the 200-day MA of 2.30, indicating a neutral trend. The MACD of -0.02 indicates Positive momentum. The RSI at 33.40 is Neutral, neither overbought nor oversold. The STOCH value of 5.42 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0239.
Pak Fah Yeow International Limited Peers Comparison
Overall Rating
HK:023982Outperform
HK:216177Outperform
HK:234874Outperform
HK:263370Outperform
HK:089758.6Neutral
HK:057058Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 82Outperform | HKD 726.12M | 7.26 | 13.59% | 8.58% | 10.63% | 39.44% | |
| 77Outperform | HKD 1.22B | 5.92 | 18.70% | 11.55% | 6.69% | 2.45% | |
| 74Outperform | HKD 1.30B | 4.80 | 6.78% | 7.33% | 6.55% | 36.62% | |
| 70Outperform | HKD 1.69B | 5.89 | 13.26% | 10.16% | -0.47% | -0.40% | |
| 59Neutral | HKD 401.18M | 100.00 | 0.34% | ― | -8.30% | -44.44% | |
| 58Neutral | HKD 5.46B | -4.47 | -4.98% | 0.32% | -15.80% | -298.94% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:0239 | Pak Fah Yeow International Limited | 2.33 | 0.12 | 5.43% | |
| HK:0570 | China Traditional Chinese Medicine Holdings Co | 1.08 | -1.23 | -53.03% | |
| HK:0897 | Wai Yuen Tong Medicine Holdings Limited | 0.36 | -0.06 | -14.29% | |
| HK:2161 | JBM (Healthcare) Ltd. | 1.48 | -1.31 | -46.93% | |
| HK:2348 | Dawnrays Pharmaceutical Holdings Ltd. | 0.86 | -0.24 | -21.89% | |
| HK:2633 | Jacobson Pharma Corporation Limited | 0.89 | -0.35 | -28.17% |
Pak Fah Yeow International Limited Corporate Events
Pak Fah Yeow boosts interim profit and dividends on healthcare growth
Pak Fah Yeow International Limited reported interim results for the six months ended 30 June 2026 showing a 6.7% year-on-year increase in revenue to HK$101.0 million and a 3.7% rise in underlying recurring profit, driven mainly by stronger sales from...
Pak Fah Yeow Declares Interim and Special Dividends for 2026
Pak Fah Yeow International Limited, incorporated in Bermuda and listed on the Hong Kong Stock Exchange, operates in the consumer healthcare sector with a focus on medicated oils and related wellness products. The board is led by Chairman Gan Wee Sean...
Pak Fah Yeow Declares Interim Dividend for First Half of 2026
Pak Fah Yeow International Limited, a Hong Kong‑listed healthcare and consumer products company, derives its business from the regional market, with shares quoted on the Main Board under stock code 00239. The board comprises a mix of executive, non‑e...
Pak Fah Yeow Declares Special Interim Dividend for First Half of 2026
Pak Fah Yeow International Limited, a Hong Kong-listed consumer healthcare company known for its medicated oils and topical remedies, generates steady cash flow from its established brands in regional markets. Its defensively positioned business and...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 05, 2026